Partnerships in Drug Delivery (PODD), Oct 27-28, 2025, Boston, MA

Join CBSET and our partner Cilcare at the 15th Annual Partnership Opportunities in Drug Delivery (PODD) conference, October 27-28, 2025, at the Westin Copley Place, Boston, MA.

Pharma, biotech and drug delivery industries will gather to assess delivery needs, explore partnership opportunities, and stay at the forefront of innovative drug delivery technologies. This includes small molecules, biologics, combination products, connected devices, cell and gene delivery, and more.

Michael Naimark, CBSET Director of Business Development

Donald Hodges, MSc, PhD, DSP, DABT – CBSET Study Director

Contact us about meeting at the PODD Conference.





    Related CBSET research:

    wpt-cell-therapy-coverWorld Pharma Today, Cell-based Therapy and FDA Review: Partnering for Success at Your pre-IND Meeting

    by Michael Naimark, MS, Director of Business Development at CBSET, Inc.

    Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings.  by Tzafriri AR, Garcia-Polite F, Li X, Keating J, Balaguer JM, Zani B, Bailey L, Markham P, Kiorpes TC, Carlyle W, Edelman ER. Journal of Controlled Release, March 28, 2018, Volume 274, Pages 102-108.

    jcrstentcoatings

    Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion on Drug Delivery, Volume 15, Issue 4, March 9, 2018, Pages 319-324.

    A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinomaIndolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER. Biomaterials, Volume 93, July 2016, Pages 71-82.

    tunabledeliveryplatformgraphic